BioLine RX LtdNASDAQ:BLRXNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.5600
- TODAY'S CHANGE (%)-0.0099 (-1.7371%)
- Bid / Lots0.5555/ 2
- Ask / Lots0.6000/ 360
- Open / Previous Close0.5660 / 0.5699
- Day Range
- 52 Week Range
- Volume150,570
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BLRX |
|---|---|---|
| 09:32 ET | 13862 | 0.566 |
| 09:36 ET | 350 | 0.568 |
| 09:38 ET | 1904 | 0.5677 |
| 09:41 ET | 1560 | 0.5662 |
| 09:43 ET | 18983 | 0.56 |
| 09:48 ET | 147 | 0.5676 |
| 09:50 ET | 500 | 0.5601 |
| 09:52 ET | 891 | 0.5601 |
| 09:59 ET | 625 | 0.5601 |
| 10:03 ET | 13406 | 0.5509 |
| 10:06 ET | 200 | 0.56 |
| 10:08 ET | 1600 | 0.56 |
| 10:14 ET | 441 | 0.5561 |
| 10:15 ET | 287 | 0.5599 |
| 10:17 ET | 1000 | 0.56 |
| 10:21 ET | 316 | 0.56 |
| 10:28 ET | 1000 | 0.5522 |
| 10:30 ET | 3792 | 0.55379 |
| 10:33 ET | 1200 | 0.556 |
| 10:35 ET | 2166 | 0.556 |
| 10:42 ET | 5700 | 0.552 |
| 10:44 ET | 200 | 0.5525 |
| 10:46 ET | 5546 | 0.552 |
| 10:48 ET | 300 | 0.552 |
| 10:51 ET | 2000 | 0.55595 |
| 10:53 ET | 8000 | 0.552 |
| 11:00 ET | 1100 | 0.552 |
| 11:04 ET | 100 | 0.552 |
| 11:09 ET | 350 | 0.5566 |
| 11:15 ET | 2100 | 0.5596 |
| 11:20 ET | 500 | 0.5596 |
| 11:24 ET | 1300 | 0.552 |
| 11:27 ET | 5700 | 0.552 |
| 11:29 ET | 1100 | 0.5558 |
| 11:44 ET | 2890 | 0.5595 |
| 11:58 ET | 200 | 0.5576 |
| 12:05 ET | 750 | 0.5592 |
| 12:14 ET | 5400 | 0.559199 |
| 12:21 ET | 604 | 0.5558 |
| 12:23 ET | 1900 | 0.5619 |
| 12:43 ET | 700 | 0.56 |
| 12:56 ET | 200 | 0.5615 |
| 12:59 ET | 2308 | 0.56022 |
| 01:01 ET | 2000 | 0.5622 |
| 01:03 ET | 1658 | 0.5593 |
| 01:06 ET | 1460 | 0.5558 |
| 01:14 ET | 100 | 0.5621 |
| 01:39 ET | 4200 | 0.5619 |
| 01:46 ET | 1500 | 0.5618 |
| 01:48 ET | 3000 | 0.5614 |
| 02:20 ET | 200 | 0.5615 |
| 02:42 ET | 100 | 0.5599 |
| 02:44 ET | 133 | 0.5577 |
| 02:49 ET | 150 | 0.5555 |
| 02:54 ET | 260 | 0.5555 |
| 02:56 ET | 200 | 0.5598 |
| 03:02 ET | 400 | 0.5555 |
| 03:03 ET | 218 | 0.555542 |
| 03:34 ET | 600 | 0.5595 |
| 03:38 ET | 11618 | 0.5574 |
| 03:43 ET | 500 | 0.5565 |
| 03:45 ET | 100 | 0.5555 |
| 03:57 ET | 100 | 0.5574 |
| 03:59 ET | 6194 | 0.56 |
Jun 3, 2024
DJ BioLine RX Price Target Maintained With a $21.00/Share by HC Wainwright & Co., from 12:45PM ET on Monday Jun 03, 2024 by Dow Jones
12:45PM ET on Monday Jun 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BioLine RX Ltd | 48.9M | -0.7x | --- |
Marker Therapeutics Inc | 48.4M | -3.9x | --- |
LAVA Therapeutics NV | 47.3M | -1.7x | --- |
Cue Biopharma Inc | 60.3M | -1.0x | --- |
Lipocine Inc | 44.1M | -4.5x | --- |
Palatin Technologies Inc | 31.5M | -0.8x | --- |
Company Information
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Contact Information
- Headquarters
- Modi'in Technology Park 2 HaMa'ayan StreetMODIIN, Israel 7177871
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Aharon Schwartz
- Chief Executive Officer
- Philip Serlin
- Chief Financial Officer
- Mali Zeevi
- Vice President - Development
- Ella Sorani
- Vice President-Clinical & Medical Affairs
- Abi Vainstein-Haras
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $48.9M |
|---|---|
Revenue (TTM) | $11.7M |
Shares Outstanding | 79.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.51 |
EPS | $-0.76 |
Book Value | $0.18 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 4.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -391.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
